Validation of PCR oligos for SARS-CoV-2 test
The global SARS-CoV-2 pandemic is an emerging, rapidly evolving situation. Therefore, increasing the test capacity to detect a virus infection is of utmost importance. BioVariance GmbH helped to fortify the regulatory submission proposal of a